Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes

Daniel Edmonston, Hillary Mulder, Elizabeth Lydon, Karen Chiswell, Zachary Lampron, Christina M. Shay, Keith Marsolo, Raj C. Shah, W Schuyler Jones, Howard S. Gordon, Wenke Hwang, Isabelle Ayoub, Daniel E. Ford, Alanna M. Chamberlain, Ajaykumar Rao, Vivian Fonseca, Alex R. Chang, Faraz S. Ahmad, Adriana M. Hung, Kelly J. Hunt, Javed Butler, Hayden B. Bosworth, Neha J. Pagidipati